Countries such as the US, UK and Canada are contemplating the need for change in how to evaluate therapies for ultra-rare diseases and potentially curative and transformative emerging technologies - what are we doing in Australia?
-
Latest News
The 'post-rebate' era has started with or without supply chain reform
Rebates were $3.2 billion in 2016-17 and $2.3 billion in 2017-18 - what happens to the supply chain reform if the 2018-19 number starts with a 1?
-
Latest News Is there even a plan for emerging therapies in Australia? August 23, 2019
-
Latest News Federal government still finalising CAR-T agreement with Peter Mac August 23, 2019The federal government is still negotiating a "detailed funding agreement" for its $80 million commitment to the Peter MacCallum Cancer Institute for its Centre for Excellence in Cellular Immunotherapy.
-
Latest News EBOS looking to 'the next wave of growth' August 23, 2019New Zealand headquartered EBOS Group, the operator of PBS full-line wholesaler Symbion, has reported flat revenue but higher earnings for the last financial year.
-
Latest News Patients might be hoping their medicine belongs to a large company August 22, 2019This is all about to be compounded because companies face the prospect of higher fees and a range of new fees under stage 2 of the 'streamlined pathways project'.
-
Latest News Government could come for more given savings shortfall August 22, 2019There is frustration over aspects of the implementation of MA's strategic agreement with the federal government - the government might also be frustrated over a savings shortfall and the sector should anticipate a response.
-
Latest News Bayer makes another move into cell therapy August 22, 2019Bayer is the latest global biopharmaceutical company to make another significant move into regenerative medicine by acquiring US-based BlueRock Therapeutics.
-
Latest News Pfizer to invest US$500m in gene therapy manufacturing August 22, 2019Pfizer has accelerated its move into new technologies, announcing it will invest US$500 million in the construction of a gene therapy manufacturing facility in the US.
-
Latest News PAGE co-founders on 'opening the door' to discussions on diversity August 21, 2019AbbVie's Kirsten O'Doherty, Pfizer's Melissa McGregor and Kathy Connell of Johnson & Johnson Innovation, discuss why companies focus on diversity, why some may not, and how PAGE has uncovered different attitudes and experiences across the sector.
-
Latest News FDA rejects Sarepta's second RNA therapy August 21, 2019The FDA has rejected Sarepta Therapeutics' second RNA therapy for the treatment of Duchenne Muscular Dystrophy - an inherited muscular wasting condition.
-
Latest News Bayer agrees to sell animal health business August 21, 2019Bayer has agreed to sell its animal health business to Eli Lilly spin-out Elanco for US$7.6 billion.
-
Latest News Sigma launches pharmacy-based telehealth service August 21, 2019Sigma has partnered with Doctors on Demand to launch InClinic - a resource that enables people to access a GP consultation online inside a pharmacy.
Latest Video
New Stories
-
The 'post-rebate' era has started with or without supply chain reform
August 23, 2019 - - Latest News -
Is there even a plan for emerging therapies in Australia?
August 23, 2019 - - Latest News -
Federal government still finalising CAR-T agreement with Peter Mac
August 23, 2019 - - Latest News -
EBOS looking to 'the next wave of growth'
August 23, 2019 - - Latest News -
Bayer makes another move into cell therapy
August 22, 2019 - - Latest News -
Government could come for more given savings shortfall
August 22, 2019 - - Latest News -
Patients might be hoping their medicine belongs to a large company
August 22, 2019 - - Latest News